Xeris Biopharma Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.11 | -$0.10 | -$0.11 |
| Q2 2024 | 1 | -$0.10 | -$0.09 | -$0.10 |
| Q3 2024 | 1 | -$0.09 | -$0.08 | -$0.09 |
| Q4 2024 | 3 | -$0.08 | -$0.03 | -$0.06 |
| Q1 2025 | 1 | -$0.09 | -$0.04 | -$0.07 |
| Q2 2025 | 1 | -$0.05 | -$0.04 | -$0.05 |
| Q3 2025 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q4 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Xeris Biopharma Holdings, Inc. Earnings Date And Information
Xeris Biopharma Holdings, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.09 by $0.03. The company had revenue of 54.27 M for the quarter and had revenue of 163.91 M for the year. Xeris Biopharma Holdings, Inc. has generated $0 earnings per share over the last year ($-0.45 diluted earnings per share) and currently has a price-to-earnings ratio of -6.85. Xeris Biopharma Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Xeris Biopharma Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q1 2025 | -$0.09 | -$0.11 | -0.02 | $51.45 M | $54.27 M |
| 08/08/2024 | Q4 2024 | -$0.11 | -$0.10 | 0.01 | $45.84 M | $48.07 M |
| 05/09/2024 | Q3 2024 | -$0.12 | -$0.14 | -0.02 | $40.64 M | |
| 03/06/2024 | Q2 2024 | -$0.09 | -$0.10 | -0.01 | $44.39 M | |
| 11/09/2023 | Q1 2024 | -$0.12 | -$0.09 | 0.03 | $40.64 M | $48.32 M |
| 08/08/2023 | Q4 2023 | -$0.13 | -$0.14 | -0.01 | $35.16 M | $38.01 M |
| 05/09/2023 | Q3 2023 | -$0.17 | -$0.12 | 0.05 | $33.20 M | |
| 03/08/2023 | Q2 2023 | -$0.16 | -$0.15 | 0.01 | $38.01 M | |
| 11/09/2022 | Q1 2023 | -$0.17 | -$0.16 | 0.01 | $29.04 M | $29.73 M |
| 08/10/2022 | Q4 2022 | -$0.23 | -$0.19 | 0.04 | $25.46 M | $25.31 M |
| 05/11/2022 | Q3 2022 | -$0.24 | -$0.25 | -0.01 | $22.07 M | |
| 03/11/2022 | Q2 2022 | -$0.42 | $21.43 M | |||
| 11/10/2021 | Q1 2022 | -$0.37 | -$0.39 | -0.02 | $11.02 M | $11.04 M |
| 08/05/2021 | Q4 2021 | -$0.31 | -$0.41 | -0.1 | $9.68 M | $8.91 M |
| 05/13/2021 | Q3 2021 | -$0.31 | -$0.30 | 0.01 | $8.05 M | |
| 03/09/2021 | Q2 2021 | -$0.39 | -$0.41 | -0.02 | $7.09 M | |
| 11/09/2020 | Q1 2021 | -$0.54 | -$0.35 | 0.19 | $4.46 M | $9.45 M |
| 08/10/2020 | Q4 2020 | -$0.71 | -$0.63 | 0.08 | $1.90 M | $2.03 M |
| 05/07/2020 | Q3 2020 | -$0.92 | -$0.89 | 0.03 | $1.79 M | |
| 03/11/2020 | Q2 2020 | -$1.23 | $1.86 M |
Xeris Biopharma Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Xeris Biopharma Holdings, Inc.'s earnings date?
Xeris Biopharma Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
-
Did Xeris Biopharma Holdings, Inc. beat their earnings estimates last quarter?
In the previous quarter, Xeris Biopharma Holdings, Inc. (:XERS) reported $-0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.09 by $0.03.
-
How can I listen to Xeris Biopharma Holdings, Inc.'s earnings conference call?
The conference call for Xeris Biopharma Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Xeris Biopharma Holdings, Inc.'s conference call transcript?
The conference call transcript for Xeris Biopharma Holdings, Inc.'s latest earnings report can be read online.
-
How much revenue does Xeris Biopharma Holdings, Inc. generate each year?
Xeris Biopharma Holdings, Inc. (:XERS) has a recorded annual revenue of $163.91 M.
-
How much profit does Xeris Biopharma Holdings, Inc. generate each year?
Xeris Biopharma Holdings, Inc. (:XERS) has a recorded net income of $163.91 M. Xeris Biopharma Holdings, Inc. has generated $-0.45 earnings per share over the last four quarters.
-
What is Xeris Biopharma Holdings, Inc.'s price-to-earnings ratio?
Xeris Biopharma Holdings, Inc. (:XERS) has a price-to-earnings ratio of -6.85 and price/earnings-to-growth ratio is 1.47.
